Compared with normal lung tissue, NSCLC specimens displayed increased composition of 37 distinct immune cell types and subtypes, including for B cells (CD19+CD20+), T cells (CD3+), CD4+ cells and CD8+ cells. This evidence concerns the gene CD8A and non-small cell lung carcinoma.